Reynaert, Niki L ; Department of Respiratory Medicine, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center+, Maastricht, the Netherlands
Cataldo, Didier ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Language :
English
Title :
Adding Weight to the Evidence: MMP-9 as a Predictor of COPD Development.
M. E. Christopoulou, E. Papakonstantinou, and D. Stolz, “Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease,” International Journal of Molecular Sciences 24, no. 4 (2023): 3786.
V. Pinto-Plata, J. Toso, K. Lee, et al., “Profiling Serum Biomarkers in Patients With COPD: Associations With Clinical Parameters,” Thorax 62, no. 7 (2007): 595–601.
Y. Higashimoto, T. Iwata, M. Okada, H. Satoh, K. Fukuda, and Y. Tohda, “Serum Biomarkers as Predictors of Lung Function Decline in Chronic Obstructive Pulmonary Disease,” Respiratory Medicine 103, no. 8 (2009): 1231–1238.
R. E. Russell, S. V. Culpitt, C. DeMatos, et al., “Release and Activity of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 by Alveolar Macrophages From Patients With Chronic Obstructive Pulmonary Disease,” American Journal of Respiratory Cell and Molecular Biology 26, no. 5 (2002): 602–609.
R. Foronjy, T. Nkyimbeng, A. Wallace, et al., “Transgenic Expression of Matrix Metalloproteinase-9 Causes Adult-Onset Emphysema in Mice Associated With the Loss of Alveolar Elastin,” American Journal of Physiology. Lung Cellular and Molecular Physiology 294, no. 6 (2008): L1149–L1157.
J. J. Atkinson, B. A. Lutey, Y. Suzuki, et al., “The Role of Matrix Metalloproteinase-9 in Cigarette Smoke-Induced Emphysema,” American Journal of Respiratory and Critical Care Medicine 183, no. 7 (2011): 876–884.
A. Churg, R. Wang, X. Wang, P. O. Onnervik, K. Thim, and J. L. Wright, “Effect of an MMP-9/MMP-12 Inhibitor on Smoke-Induced Emphysema and Airway Remodelling in Guinea Pigs,” Thorax 62, no. 8 (2007): 706–713.
X. Ran, F. Wu, Z. Wang, et al., “Elevated MMP-9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis,” Respirology (2025), https://doi.org/10.1111/resp.70099.
F. Wu, Y. Zhou, J. Peng, et al., “Rationale and Design of the Early Chronic Obstructive Pulmonary Disease (ECOPD) Study in Guangdong, China: A Prospective Observational Cohort Study,” Journal of Thoracic Disease 13, no. 12 (2021): 6924–6935.
K. Ostridge, N. Williams, V. Kim, et al., “Relationship Between Pulmonary Matrix Metalloproteinases and Quantitative CT Markers of Small Airways Disease and Emphysema in COPD,” Thorax 71, no. 2 (2016): 126–132.
S. Bekaert, M. Fillet, B. Detry, et al., “Inflammation-Generated Extracellular Matrix Fragments Drive Lung Metastasis,” Cancer Growth Metastasis 10 (2017): 1179064417745539.
D. Cataldo, C. Munaut, A. Noel, et al., “Matrix Metalloproteinases and TIMP-1 Production by Peripheral Blood Granulocytes From COPD Patients and Asthmatics,” Allergy 56, no. 2 (2001): 145–151.
E. Papakonstantinou, G. Karakiulakis, S. Batzios, et al., “Acute Exacerbations of COPD Are Associated With Significant Activation of Matrix Metalloproteinase 9 Irrespectively of Airway Obstruction, Emphysema and Infection,” Respiratory Research 16, no. 1 (2015): 78.
T. A. Omachi, M. D. Eisner, A. Rames, L. Markovtsova, and P. D. Blanc, “Matrix Metalloproteinase-9 Predicts Pulmonary Status Declines in Alpha1-Antitrypsin Deficiency,” Respiratory Research 12, no. 1 (2011): 35.
J. M. Wells, M. M. Parker, R. A. Oster, et al., “Elevated Circulating MMP-9 Is Linked to Increased COPD Exacerbation Risk in SPIROMICS and COPDGene,” JCI Insight 3, no. 22 (2018): e123614.
